|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123 IDR | +6.03% |
|
+21.78% | -89.26% |
| May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was IDR 313,614.13 million compared to IDR 307,111.03 million a year ago. Net loss was IDR 36,686.17 million compared to net income of IDR 9,051.65 million a year ago.
Basic loss per share from continuing operations was IDR 68.56 compared to basic earnings per share from continuing operations of IDR 16.92 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -89.26% | 86.17M | |
| +40.00% | 723B | |
| +34.28% | 595B | |
| -3.73% | 369B | |
| +20.32% | 332B | |
| +2.83% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| +0.00% | 168B |
PT PYRIDAM FARMA TBK 
